the drug development market is also growing. King's College London is one of the top universities...
The European Investment Fund in Luxembourg City and Cancer Research Technology (CRT), the commercial arm of the London-based charity Cancer Research UK, are jointly investing |[pound]|50 million in the development of potential cancer drugs.
with the theme "Exploring the recent trends and advances in the field of Drug Discovery research and innovations in the pharma" emphasizing on recent areas of more optimized research techniques like rational and computer aided drug designing for the Discovery, Designing and Development of new drugs ...
https://wellcome.ac.uk/reports/regulation-clinical-trials-brexit-and-beyond 8. Golding BT, Waring MJ. The consequences of ‘Brexit’ for drug discovery and development, and the regulatory implications. Expert Opin Drug Discov. 2018;13(7):583-585. doi:10.1080/17460441.2018.1463215...
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.
This has been a busy week in the field of neuroscience drug discovery, with EU approval for a long-acting schizophrenia treatment, research revealing new insights into autism, the formation of a partnership focused on ALS drug development and the launch of a new […] Whitepaper: Explore iPSC...
Drug development company Ellipses Pharma now has more than 200 oncology experts from 106 institutions worldwide providing analysis and advice on selection of the most promising potential cancer medicines in its Scientific Affairs Group (SAG). The number of experts joining the SAG has increased by 53...
Scientifically rigorous, extensive in scale Our global lab footprint, vast clinical data and scientific expertise help accelerate the drug development process. Learn More LABCORP ONDEMAND Stop wondering. Go test yourself. Explore over 50 self-ordered lab tests and get answers about your health. ...
December 24, 2024 · 223 min read · BioSpace Editorial Staff Approvals Ionis’ Tryngolza Becomes First FDA-Approved Therapy for Familial Chylomicronemia Syndrome December 20, 2024 · 2 min read · ...
This speeds up the process of finding new drugs and makes drug development more targeted and effective. For instance, in the context of COVID-19, in the beginning, because of the lack of specific effective antiviral therapies, a wide variety of strategies have been investi- gated to fight ...